Investigating cancer disparities in Black patients through genetics and environmental factors

SAMBAI: Societal, Ancestry and Molecular Biology Analyses of Inequalities

['FUNDING_OTHER'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-11046932

This study is looking into why Black patients, especially those from West Africa, tend to have higher rates of aggressive cancers like prostate, breast, and pancreatic cancer, and it aims to gather important information to help improve cancer care for these communities.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorNEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-11046932 on ClinicalTrials.gov

What this research studies

This research focuses on understanding the reasons behind higher rates of aggressive cancers, such as prostate, breast, and pancreatic cancers, in Black patients, particularly those from West Africa. The team will analyze genetic, environmental, and social factors that contribute to these disparities, using advanced genomic techniques and data collection methods. By creating a biobank and data repository, they aim to gather comprehensive information that can help identify the causes of these inequalities and improve cancer outcomes for underserved populations. The research will involve collaboration with scientists from the US, Africa, and the UK to ensure a diverse and inclusive approach.

Who could benefit from this research

Good fit: Ideal candidates for this research include Black patients, particularly those with a family history of prostate, breast, or pancreatic cancers.

Not a fit: Patients who do not identify as Black or do not have a relevant family history of the targeted cancers may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment of aggressive cancers in Black patients, ultimately reducing health disparities.

How similar studies have performed: Previous research has shown success in addressing cancer disparities through genetic and environmental analyses, indicating that this approach has potential for impactful findings.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.